Preview

Obstetrics, Gynecology and Reproduction

Advanced search

A systematic analysis of vascular paroxysm pathophysiology in perimenopause: methods for nutritional correction

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.167

Full Text:

Abstract

Materials and Methods. A systematic analysis of publications retrieved from PubMed/MEDLINE database as well as in the list of primary sources of the identified scientific papers was carried out by using current methods for large data analysis within the framework of topological and metric approaches applied for data recognition/classification. A map of molecular-pathophysiological processes was compiled followed by performing analysis of metric condensations.

Results. Three clusters of terms describing an impact of various biological processes into the pathophysiology of hot flushes were identified: inflammation combined with insulin resistance (cluster 1), the presence of chronic comorbid pathologies in patients (cluster 2), and disorders of serotonin metabolism (cluster 3). The use of menopausal hormone therapy (MHT) is not accepted for all patients. A promising direction in treatment of mild and moderate hot flushes is based on using nutraceuticals: vitamins, trace elements and substances obtained from plant extracts (isoflavones, phytoestrogens, etc.). Here, this set of interactions between pathophysiology of hot flushes and deficiency of certain micronutrients, inflammation, insulin resistance, chronic comorbid pathologies and disorders of serotonin metabolism is described. Replenished deficiency of vitamins C, E, A, B2, PP, B6, B12, and folates aids to reduce chronic inflammation, insulin resistance and normalize functioning of the autonomic nervous system. Natural and synthetic agonists of GABA receptors and tryptophan derivatives are necessary for serotonin biosynthesis and elimination of other neurotransmitter imbalances in order to normalize activity of the hypothalamic thermoregulatory region.

Conclusion. Plant isoflavones (including phytoestrogens) together with vitamins and other micronutrients help to overcome estrogen-dependent withdrawal symptoms and eliminate dysfunction of autonomic nervous system

About the Authors

O. A. Gromova
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management», Russian Academy of Sciences; Big Data Storage and Analysis Center, Lomonosov Moscow State University
Russian Federation

Olga A. Gromova - MD, Dr Sci Med, Professor, Leading Researcher, Scientific Director

42 Vavilova Str., Moscow 119333

1 Leninskie gory, Moscow 119234

Scopus Author ID: 7003589812

Researcher ID: J-4946-2017

Author ID: 94901. WOS ID: J-4946-2017



I. Yu. Torshin
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management», Russian Academy of Sciences; Big Data Storage and Analysis Center, Lomonosov Moscow State University
Russian Federation

Ivan Yu. Torshin - PhD (Chemistry), PhD in Applied Mathematics, Senior Researcher

42 Vavilova Str., Moscow 119333

1 Leninskie gory, Moscow 119234

Scopus Author ID: 7003300274

Researcher ID: C-7683-2018

Author ID: 54104

WOS ID: C-7683-2018



O. A. Limanova
Ivanovo State Medical Academy, Health Ministry of Russian Federation
Russian Federation

Olga A. Limanova - MD, PhD, Associate Professor, Department of Pharmacology

8 Sheremetyevskiy Ave., Ivanovo 153012

Scopus Author ID: 23013489000

WoS ID: A-7504-2016



N. I. Tapilskaya
Research Institute of Obstetrics, Gynecology and Reproductology named after D. O. Ott; Saint Petersburg State Pediatric Medical University, Health Ministry of Russian Federation
Russian Federation

Natalia I. Tapilskaya - MD, Dr Sci Med, Professor, Leading Researcher, Department of Assisted Reproductive Technologies; Professor, Department of Obstetrics and Gynecology

3 Mendeleevskaya liniya, Saint Petersburg 199034

2 Litovskaya Str., Saint Petersburg 194100

Scopus Author ID: 23013489000

WoS ID: A-7504-2016



References

1. Parazzini F. Resveratrol, tryptophanum, glycine and vitamin E: a nutraceutical approach to sleep disturbance and irritability in peri- and post-menopause. Minerva Ginecol. 2015;67(1):1–5. PMID: 25660429.

2. Gromova O. A., Torshin I. Yu., Limanova O. A., Nikonov A. A. Pathophysiology of vegetative-vascular paroxysms (hot flashes) during menopause in women and mechanisms of action of β-alanine. New clinical and pharmacological concept. [Patofiziologiya vegetativnososudistyh paroksizmov (prilivy) v period menopauzy u zhenshchin i mekhanizmy vozdejstviya β-alanina. Novaya klinikofarmakologicheskaya koncepciya]. Ginekologia. 2010;12(2):29–36. (In Russ.).

3. Torshin I. Yu., Gromova O. A., Limanova O. A. The “quick effect” of klimalanin (β-alanine) on hot flushes: a comparative study of the interactions of β-alanine, taurine and glycine with glycine receptors. [«Bystryj effekt» klimalanina (β-alanina) pri prilivah: sravnitel’noe issledovanie vzaimodejstvij β-alanina, taurina i glicina s glicinovymi receptorami]. Ginekologia. 2012;14(2):65–9. (In Russ.).

4. Shanafelt T. D., Barton D. L., Adjei A. A., Loprinzi C. L. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002;77(11):1207–18. https://doi.org/10.4065/77.11.1207. PMID: 12440557.

5. Maclennan A. H., Broadbent J. L., Lester S., Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;2004(4):CD002978. https://doi.org/10.1002/14651858.CD002978.pub2. PMID: 15495039.

6. Rabin D. S., Cipparrone N., Linn E. S., Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause. 1999;6(1):61–7. PMID: 10100182.

7. Rossouw J. E., Anderson G. L., Prentice R. L. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33. https://doi.org/10.1001/jama.288.3.321. PMID: 12117397.

8. Lacey J. V., Mink P. J., Lubin J. H. et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288(3):334–41. https://doi.org/10.1001/jama.288.3.334. PMID: 12117398.

9. Coughlin S. S., Giustozzi A., Smith S. J., Lee N. C. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol. 2000;53(4):367–75. https://doi.org/10.1016/s0895-4356(99)00179-1. PMID: 10785567.

10. Tanis B. C., van den Bosch M. A., Kemmeren J. M. et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345(25):1787–93. https://doi.org/10.1056/NEJMoa003216. PMID: 11752354.

11. Gromova O. A., Torshin I. Yu., Limanova O. A. et al. The comparative study of evidence based data concerning efficacy and safety of oral and transdermal estrogen replacement therapy in women of different age. [Sravnitel’noe issledovanie dokazatel’noj bazy effektivnosti i bezopasnosti primeneniya peroral’noj i transdermal’noj form zamestitel’noj gormonal’noj terapii estrogenami u zhenshchin v razlichnye vozrastnye periody]. Problemy reprodukcii. 2013;(6):86–96. (In Russ.).

12. Pinkerton J. V., James A. H. Management of menopausal symptoms for women who are at high risk of thrombosis. Clin Obstet Gynecol. 2018;61(2):260–8. https://doi.org/10.1097/GRF.0000000000000358. PMID: 29419532.

13. Nachtigall L. E., Baber R. J., Barentsen R. et al. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can. 2006;28(4):279–89. https://doi.org/10.1016/S1701-2163(16)32136-3. PMID: 16776904.

14. Shen W., Stearns V. Treatment strategies for hot flushes. Expert Opin Pharmacother. 2009;10(7):1133–44. https://doi.org/10.1517/14656560902868217. PMID: 19405789.

15. Melis G. B., Gambacciani M., Cagnacci A. et al. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. Obstet Gynecol. 1988;72(5):688–92. PMID: 3140150.

16. Barton D. L., Loprinzi C. L., Quella S. K. et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998;16(2):495–500. https://doi.org/10.1200/JCO.1998.16.2.495. PMID: 9469333.

17. Bourre J. M. Dietary omega-3 fatty acids for women. Biomed Pharmacother. 2007;61(2–3):105–12. https://doi.org/10.1016/j.biopha.2006.09.015. PMID: 17254747.

18. Gromova O. A., Torshin I. Yu., Tetruashvili N. K. et al. Molecular mechanisms for pharmacological effects of drugs based on Cimicifuga racemosa extracts. [Molekulyarnye mekhanizmy osushchestvleniya farmakologicheskih effektov preparatov na osnove ekstraktov Cimicifuga racemosa]. Ginekologiya. 2018;20(1):39–46. (In Russ.).

19. Torshin I. Yu., Gromova O. A., Limanova O. A. Systematic analysis of composition and molecular mechanisms of the Vitex Agnus-castus standardized extracts. [Sistematicheskij analiz sostava i mekhanizmov molekulyarnogo vozdejstviya standartizovannyh ekstraktov Vitex Agnus-castus]. Trudnyj pacient. 2015;13(1–2):19–28. (In Russ.).

20. Torshin I. Y., Rudakov K. V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 1: factorization approach. Pattern Recognition and Image Analysis. 2017;27(1):16–28. https://doi.org/10.1134/S1054661817010151.

21. Torshin I. Yu., Rudakov K. V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis. 2017;27(2):184–99. https://doi.org/10.1134/S1054661817020110.

22. Torshin I. Y. Optimal dictionaries of the final information on the basis of the solvability criterion and their applications in bioinformatics. Pattern Recognition and Image Analysis. 2013;23(2):319–27. https://doi.org/10.1134/S1054661813020156.

23. Torshin I. Yu., Rudakov K. V. On the theoretical basis of the metric analysis of poorly formalized problems of recognition and classification. Pattern Recognition and Image Analysis. 2015;25(4):577–87. https://doi.org/10.1134/S1054661815040252.

24. Torshin I. Yu., Rudakov K. V. On metric spaces arising during formalization of problems of recognition and classification. Part 2: density properties. Pattern Recognition and Image Analysis. 2016;26(3):483–496. https://doi.org/10.1134/S1054661816030202.

25. Menopause medicine. Ed. V. P. Smetnik. [Medicina klimakteriya. Pod red. V. P. Smetnik]. Moskva: Litera, 2006. 847 s.

26. Arendt M., Rosenberg R., Foldager L. et al. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict. 2007;16(6):461–7. https://doi.org/10.1080/10550490701640985. PMID: 18058411.

27. Karaoulanis S. E., Daponte A., Rizouli K. A. et al. The role of cytokines and hot flashes in perimenopausal depression. Ann Gen Psychiatry. 2012;11:9. https://doi.org/10.1186/1744-859X-11-9. PMID: 22490187.

28. Casper R. F., Yen S. S. Neuroendocrinology of menopausal flushes: a hypothesis of flush mechanism. Clin Endocrinol (Oxford). 1985;22(3):293–312. https://doi.org/10.1111/j.1365-2265.1985.tb03243.x. PMID: 3884189.

29. Hairi H. A., Shuid A. N., Ibrahim N. et al. The effects and action mechanisms of phytoestrogens on vasomotor symptoms during menopausal transition: thermoregulatory mechanism. Curr Drug Targets. 2019;20(2):192–200. https://doi.org/10.2174/1389450118666170816123740. PMID: 28814228.

30. Chen L. R., Ko N. Y., Chen K. H. Isoflavone supplements for menopausal women: A systematic review. Nutrients. 2019;11(11):2649. https://doi.org/10.3390/nu11112649. PMID: 31689947.

31. Singhal S. R., Shullai W. K. Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms. J Midlife Health. 2016;7(3):132–9. https://doi.org/10.4103/0976-7800.191017. PMID: 27721641.

32. Lambert M. N.T., Thorup A. C., Hansen E. S.S., Jeppesen P. B. Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms. PLoS One. 2017;12(6):e0176590. https://doi.org/10.1371/journal.pone.0176590. PMID: 28591133.

33. Lee J. H., Dean M., Austin J. R. et al. Irilone from Red Clover (Trifolium pratense) Potentiates Progesterone Signaling. J Nat Prod. 201828;81(9):1962–7. https://doi.org/10.1021/acs.jnatprod.8b00131. PMID: 30199256.

34. Coon J. T., Pittler M. H., Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine. 2007;14(2–3):153–9. https://doi.org/10.1016/j.phymed.2006.12.009.

35. Myers S. P., Vigar V. Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80 mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine. 2017;24:141–7. https://doi.org/10.1016/j.phymed.2016.12.003.

36. Palacios S., Lilue M., Mejia A., Menendez C. Omega-3 versus isoflavones in the control of vasomotor symptoms in postmenopausal women. Gynecol Endocrinol. 2017;33(12):951–7. https://doi.org/10.1080/09513590.2017.1332588.

37. Vahid Dastjerdi M., Eslami B., Alsadat Sharifi M. et al. Effect of soy isoflavone on hot flushes, endometrial thickness, and breast clinical as well as sonographic features. Iran J Public Health. 2018;47(3):382–9. PMID: 29845026.

38. Perna S., Peroni G., Miccono A. et al. Multidimensional effects of soy isoflavone by food or supplements in menopause women: a systematic review and bibliometric analysis. Nat Prod Commun. 2016;11(11):1733–40. PMID: 30475519.

39. Kuznetsova I. V. Non hormonal management options for menstrual cycle irregularities. [Vozmozhnosti negormonal’noj korrekcii narushenij menstrual’nogo cikla]. Medicinskij sovet. 2019;(13):16–27. (In Russ.). https://doi.org/10.21518/2079-701X-2019-13-16-27.

40. Gromova O. A., Rebrov V. G. Vitamins, macro- and microelements: educational programs of RSC of UNESCO Institute of Microelements. [Vitaminy, makro- i mikroelementy. Obuchayushchie programmy RSC instituta mikroelementov YuNESKO]. Moskva: GEOTAR-Media, 2008. 954 c. (In Russ.). ISBN: 978-5-9704-0814-8.

41. Freedman R. R., Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol. 1999;181(1):66–70. https://doi.org/10.1016/s0002-9378(99)70437-0.

42. Andrikoula M., Prelevic G. Menopausal hot flushes revisited. Climacteric. 2009;12(1):3–15. https://doi.org/10.1080/13697130802556296.

43. Bansal R., Aggarwal N. Menopausal hot flashes: a concise review. J Midlife Health. 2019;10(1):6–13. https://doi.org/10.4103/jmh.JMH_7_19.

44. Berendsen H. H. The role of serotonin in hot flushes. Maturitas. 2000;36(3):155–64. https://doi.org/10.1016/s0378-5122(00)00151-1.

45. Montasser M. E., Ziv-Gal A., Brown J. P. et al. A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes. Menopause. 2015;22(1):108–13. https://doi.org/10.1097/GME.0000000000000291.

46. Carroll D. G. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician. 2006;73(3):457–64. PMID: 16477892.

47. McGarry K., Geary M., Gopinath V. Beyond estrogen: treatment options for hot flashes. Clin Ther. 2018;40(10):1778–86. https://doi.org/10.1016/j.clinthera.2018.08.010.

48. Toulis K. A., Tzellos T., Kouvelas D., Goulis D. G. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Clin Ther. 2009;31(2):221–35. https://doi.org/10.1016/j.clinthera.2009.02.006.

49. Flores-Ramos M., Moreno J., Heinze G. et al. Gonadal hormone levels and platelet tryptophan and serotonin concentrations in perimenopausal women with or without depressive symptoms. Gynecol Endocrinol. 2014;30(3):232–5. https://doi.org/10.3109/09513590.2013.875994.

50. Blümel J. E., Palacios S., Legorreta D. et al. Is fibromyalgia part of the climacteric syndrome? Maturitas. 2012;73(2):87–93. https://doi.org/10.1016/j.maturitas.2012.06.001.

51. Chattha R., Nagarathna R., Padmalatha V., Nagendra H. R. Effect of yoga on cognitive functions in climacteric syndrome: a randomised control study. BJOG. 2008;115(8):991–1000. https://doi.org/10.1111/j.1471-0528.2008.01749.x.

52. Miquel J., Ramírez-Boscá A., Ramírez-Bosca J.V., Alperi J. D. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr. 2006;42(3):289–306. https://doi.org/ 10.1016/j.archger.2005.08.005.

53. Sanchez ibanez J. M. Treatment of hot flashes of the menopause with vitamin E. Rev Esp Obstet Ginecol. 1951;8(58):247–51. PMID: 14900635.

54. Ataei-Almanghadim K., Farshbaf-Khalili A., Ostadrahimi A. R. et al. The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial. Complement Ther Med. 2020;48:102267. https://doi.org/10.1016/j.ctim.2019.102267.

55. Bani S., Hasanpour S., Farzad Rik L. et al. The effect of folic acid on menopausal hot flashes: a randomized clinical trial. J Caring Sci. 2013;2(2):131–40. https://doi.org/10.5681/jcs.2013.016.

56. Gaweesh S. S., Abdel-Gawad M.M., Nagaty A. M., Ewies A. A. Folic acid supplementation may cure hot flushes in postmenopausal women: a prospective cohort study. Gynecol Endocrinol. 2010;26(9):658–62. https://doi.org/10.3109/09513591003686288.

57. Odai T., Terauchi M., Hirose A. et al. Severity of hot flushes is inversely associated with dietary intake of vitamin B(6) and oily fish. Climacteric. 2019;22(6):617–21. https://doi.org/10.1080/13697137.2019.1609440.

58. Rubashkina A. N., Lapochkina N. P., Torshin I. Yu., Gromova O. A. 7-hydroxymatairesinol in modulation of estrogen metabolism and therapy of mastopathy. [7-gidroksimatairezinol v modulyacii metabolizma estrogenov i terapii mastopatii]. Ginekologiya. 2020;22(4). (In Russ.). https://doi.org/10.26442/20795696.2020.4.200183.


For citation:


Gromova O.A., Torshin I.Yu., Limanova O.A., Tapilskaya N.I. A systematic analysis of vascular paroxysm pathophysiology in perimenopause: methods for nutritional correction. Obstetrics, Gynecology and Reproduction. 2020;14(3):361-373. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.167

Views: 90


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)